These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 18176653)
1. Oral adverse effects due to the use of Nevirapine. Moura MD; Senna MI; Madureira DF; Fonseca LM; Mesquita RA J Contemp Dent Pract; 2008 Jan; 9(1):84-90. PubMed ID: 18176653 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients]. Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327 [TBL] [Abstract][Full Text] [Related]
3. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006. Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758 [TBL] [Abstract][Full Text] [Related]
5. Nevirapine-associated rash in a Jamaican child with HIV/AIDS. Steel-Duncan JC; Pierre R; Gabay L; Christie CD West Indian Med J; 2004 Oct; 53(5):356-8. PubMed ID: 15675504 [TBL] [Abstract][Full Text] [Related]
6. Serious toxicity associated with continuous nevirapine-based HAART in pregnancy. van Schalkwyk JE; Alimenti A; Khoo D; Maan E; Forbes JC; Burdge DR; Gilgoff S; Money DM BJOG; 2008 Sep; 115(10):1297-302. PubMed ID: 18715416 [TBL] [Abstract][Full Text] [Related]
7. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
8. Orofacial effects of antiretroviral therapies. Scully C; Diz Dios P Oral Dis; 2001 Jul; 7(4):205-10. PubMed ID: 11575869 [TBL] [Abstract][Full Text] [Related]
9. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114 [TBL] [Abstract][Full Text] [Related]
10. HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients. Chantarangsu S; Mushiroda T; Mahasirimongkol S; Kiertiburanakul S; Sungkanuparph S; Manosuthi W; Tantisiriwat W; Charoenyingwattana A; Sura T; Chantratita W; Nakamura Y Pharmacogenet Genomics; 2009 Feb; 19(2):139-46. PubMed ID: 19104471 [TBL] [Abstract][Full Text] [Related]
11. Adverse effects of antiretroviral therapy in HIV-1 infected children. Shah I J Trop Pediatr; 2006 Aug; 52(4):244-8. PubMed ID: 16126803 [TBL] [Abstract][Full Text] [Related]
12. High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients. Rey D; Hoen B; Chavanet P; Schmitt MP; Hoizey G; Meyer P; Peytavin G; Spire B; Allavena C; Diemer M; May T; Schmit JL; Duong M; Calvez V; Lang JM J Antimicrob Chemother; 2009 Feb; 63(2):380-8. PubMed ID: 19036752 [TBL] [Abstract][Full Text] [Related]
13. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients. Ortega KL; Vale DA; Magalhães MH J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845 [TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire. Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864 [TBL] [Abstract][Full Text] [Related]
15. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection. Santos RP; Ramilo O; Barton T Pediatr Infect Dis J; 2007 Nov; 26(11):1053-6. PubMed ID: 17984815 [TBL] [Abstract][Full Text] [Related]
16. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR; Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042 [TBL] [Abstract][Full Text] [Related]
17. Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin. Olawumi HO; Olatunji PO; Salami AK; Odeigah L; Iseniyi JO Niger J Clin Pract; 2008 Dec; 11(4):312-5. PubMed ID: 19320401 [TBL] [Abstract][Full Text] [Related]
18. Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients. Kong HH; Myers SA Dermatol Ther; 2005; 18(1):58-66. PubMed ID: 15842613 [TBL] [Abstract][Full Text] [Related]
19. Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients. Kumarasamy N; Venkatesh KK; Cecelia AJ; Devaleenal B; Lai AR; Saghayam S; Balakrishnan P; Yepthomi T; Poongulali S; Flanigan TP; Solomon S; Mayer KH AIDS Patient Care STDS; 2008 Apr; 22(4):337-44. PubMed ID: 18422462 [TBL] [Abstract][Full Text] [Related]
20. Effects of nevirapine, compared with lamivudine, on lipids and lipoproteins in HIV-1-uninfected newborns: the stopping infection from mother-to-child via breast-feeding in Africa lipid substudy. Sankatsing RR; Wit FW; Pakker N; Vyankandondera J; Mmiro F; Okong P; Kastelein JJ; Lange JM; Stroes ES; Reiss P J Infect Dis; 2007 Jul; 196(1):15-22. PubMed ID: 17538878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]